IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 114 filers reported holding IRADIMED CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,364,965 | -6.6% | 53,301 | +0.5% | 0.01% | 0.0% |
| Q2 2023 | $2,531,270 | +18.4% | 53,022 | -2.4% | 0.01% | +11.1% |
| Q1 2023 | $2,137,492 | +491.9% | 54,320 | +325.5% | 0.01% | +350.0% |
| Q4 2022 | $361,150 | +24.5% | 12,766 | +32.3% | 0.00% | 0.0% |
| Q3 2022 | $290,000 | +16.9% | 9,646 | +32.0% | 0.00% | +100.0% |
| Q2 2022 | $248,000 | -26.4% | 7,306 | -2.7% | 0.00% | 0.0% |
| Q1 2022 | $337,000 | -51.6% | 7,506 | -50.2% | 0.00% | -66.7% |
| Q4 2021 | $697,000 | +37.5% | 15,086 | 0.0% | 0.00% | +50.0% |
| Q3 2021 | $507,000 | +4.1% | 15,086 | -8.9% | 0.00% | 0.0% |
| Q2 2021 | $487,000 | +10.2% | 16,556 | -3.4% | 0.00% | 0.0% |
| Q1 2021 | $442,000 | +7.3% | 17,146 | -5.2% | 0.00% | 0.0% |
| Q4 2020 | $412,000 | -1.4% | 18,086 | -7.4% | 0.00% | 0.0% |
| Q3 2020 | $418,000 | – | 19,536 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
| RK Capital | 222,914 | $5,212,000 | 1.95% |
| Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
| Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
| Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
| CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
| ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
| Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |